A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
Explore this paper's citation graph
Summary
It is confirmed that acute pyelonephritis in the female patients caused by ESBL-producing strains could not be treated with ceftriaxone.
- Type
- article
- Published
- 2008-08-01
- Cited by
- 23
- References
- 40
- OpenAlex
- https://openalex.org/W100053945
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:800065
Keywords
Ceftriaxone, Medicine, Proteus mirabilis, Cephalosporin, Antibiotics
References
- Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center
- Pseudomonas aeruginosa: resistance and therapy.
- The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
- Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).
- Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein
- Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
- Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.
- Risk Factors for and Clinical Outcomes of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
- Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit.
- Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.
- The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital.
- Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
- Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia.
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
- Extended-spectrum beta-lactamase-producing Escherichiacoli and Klebsiellapneumoniae bloodstream infection: risk factors and clinical outcome
- Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).
- A 5‐year epidemiological study of extended‐spectrum ββ‐lactamase‐producing Klebsiella pneumoniae isolates in a medium‐ and long‐stay neurological unit
- Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period
- Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia.
Cited by
- Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae : Treatment, Selection and International Spread
- Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia
- Nouvelles stratégies thérapeutiques contre les entérobactéries productrices de β-lactamases à spectre étendu
- Selection of first-line i.v. antibiotics for acute pyelonephritis in patients requiring emergency hospital admission
- Les entérobactéries productrices de β-lactamases à spectre étendu (BLSE) et les céphalosporines de troisième génération en 2012
- A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis.
- Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase
- Prevalence of antibiotic resistant bacteria in healthy adults, foods, food animals, and the environment in selected areas in Thailand
- Expert Systems in Clinical Microbiology
- Diagnostic and Treatment Difficulties of Pyelonephritis in Pregnancy in Resource-Limited Settings
- Thailand Antimicrobial Resistance Containment and Prevention Program.
- In vitro and in vivo activity of tebipenem against ESBL-producing E. coli.
- THE EVOLUTION OF SOME BIOCHEMICAL MARKERS AT PATIENTS WITH B HEPATITIS VIRUS
- A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study.
- In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model
- Carbapenem and Colistin Resistance in Enterobacteriaceae in Southeast Asia: Review and Mapping of Emerging and Overlapping Challenges.
- Fecal Carriage Rate of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae as a Proxy Composite Indicator of Antimicrobial Resistance in a Community in Thailand
- Calculation of the optimal structure of antibiotic consumption in a hospital based on the predicted antimicrobial resistance in the treatment of uncomplicated acute pyelonephritis
- Escherichia coli: An arduous voyage from commensal to Antibiotic-resistance.
- Antimicrobial Susceptibility Among Urinary Bacterial Pathogens in King Chulalongkorn Memorial Hospital
Related papers
- Effectiveness of oral antibiotics for treating pyelonephritis caused by extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae: A case series
- Urinary Tract Infections are becoming Multi-drug Resistant due to Extended Spectrum Beta-lactamases-producing Klebsiella pneumonia
- In vivo susceptibility of ESBL producing Escherichia coli to ceftriaxone in children with acute pyelonephritis.
- Detection of ESBL-producing strains isolated from patients with postoperative lung infections and antimicrobial resistance analysis
- Evolution of the Antimicrobial resistance of Bacteria causing Urinary Tract Infections.
- [Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase].
- Studies on clinical data and drug-resistance of Klebsiella Pneumoniae in 60 lung infectious patients
- Infection and antibiotic resistance of Klebsiella pneumoniae in neonates
- Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae